Surgical Science has entered into an agreement to acquire a company within the robotic surgery segment
Surgical Science Sweden AB (publ) ("Surgical Science" or the "Company") has entered into a conditional agreement to acquire all shares outstanding of Mimic Technologies Inc. (“Mimic”) for an initial consideration of USD 18.0 million (approximately SEK 150 million) on a cash and debt-free basis. In addition, a maximum deferred contingent consideration of USD 15.6 million (approximately SEK 130 million) tied to qualifying revenue targets for the years 2021, 2022 and 2023 may be paid. The maximum total consideration, given that all conditions are met, amounts therefore to USD 33.6 million (